What is Beam Therapeutics's capex?

Beam Therapeutics (BEAM) reported capex of $2.23M in Q1 2026.

How has Beam Therapeutics's capex changed year-over-year?

Beam Therapeutics's capex decreased by 27.2% year-over-year, from $3.07M to $2.23M.

What is the long-term trend for Beam Therapeutics's capex?

Over 4 years (2021 to 2025), Beam Therapeutics's capex has grown at a -24.8% compound annual growth rate (CAGR), from $46.81M to $14.95M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Beam Therapeutics BEAM CapEx

CapEx at other companies

Vertex PharmaceuticalsVRTX

$133.4M+228%

Arrowhead ResearchARWR

$2.57M-51.6%

CRISPR TherapeuticsCRSP

$504K+145%

Cogent Biosciences, Inc.COGT

$449K-17.9%

PTC TherapeuticsPTCT

$1.2M-30.6%

BridgeBio PharmaBBIO

$69K—

Other financials

Income statement

See full

Revenue$31.7M+325%

Operating income-$107.2M+10.1%

Net income-$94.3M+12.9%

EPS (diluted)-$0.91+26.0%

Balance sheet

See full

Cash & equivalents$288.3M-45.4%

Total debt$250.8M+58.6%

Total equity$1.2B+3.1%

Total assets$1.5B+0.9%

Cash flow

See full

Operating cash flow-$128.5M-23.7%

Free cash flow-$130.7M-22.2%

Valuation

See full

Market cap$3.51B+24.5%

Enterprise value$3.47B+51.2%

P/S21.4×-23.0×

Profitability

See full

Operating margin-226.6%-90.5pp

Net margin-742.7%—

FCF margin-234%-86.6pp

Returns & leverage

See full

Return on equity-47.1%—

Debt / equity0.2×+0.1×

Current ratio17×+8.2×

Where this comes from

Reported directly by Beam Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beam Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beam Therapeutics's capex?: Beam Therapeutics (BEAM) reported capex of $2.23M in Q1 2026.
How has Beam Therapeutics's capex changed year-over-year?: Beam Therapeutics's capex decreased by 27.2% year-over-year, from $3.07M to $2.23M.
What is the long-term trend for Beam Therapeutics's capex?: Over 4 years (2021 to 2025), Beam Therapeutics's capex has grown at a -24.8% compound annual growth rate (CAGR), from $46.81M to $14.95M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.